CellBio  Vol.3 No.4 , December 2014
The Mitochondrial Pyruvate Carrier and Metabolic Regulation
Abstract: Pyruvate is a key intermediate at the branchpoint of anaerobic and aerobic energy metabolism. Its transport into the mitochondrial matrix is necessary prior to its decarboxylation into acetyl-CoA, which feeds the reducing equivalent-generating tricarboxylic acid (TCA) cycle. Although the existence of specific carrier transport of cytosolic pyruvate into the mitochondria has been inferred from a myriad of studies, the identities of the mitochondrial pyruvate carrier (MPC) were only confirmed very recently. Identification of the MPC facilitated several other recent advances. These include the finding of MPC’s inhibition by the insulin-sensitizing drug family thiazolidinediones, how cells respond flexibly to a reduction in MPC functionality, as well as insights into how changes in MPC levels affect oncogenic potential of cancer cells. These new findings, discussed here in this brief review, have important implications in therapeutic approaches towards metabolic disorders and cancer.
Cite this paper: Tang, B. (2014) The Mitochondrial Pyruvate Carrier and Metabolic Regulation. CellBio, 3, 111-117. doi: 10.4236/cellbio.2014.34011.

[1]   Papa, S., Francavilla, A., Paradies, G. and Meduri, B. (1971) The Transport of Pyruvate in Rat Liver Mitochondria. FEBS Letters, 12, 285-288.

[2]   Halestrap, A.P. and Denton, R.M. (1974) Specific Inhibition of Pyruvate Transport in Rat Liver Mitochondria and Human Erythrocytes by alpha-Cyano-4-hydroxycinnamate. Biochemical Journal, 138, 313-316.

[3]   Halestrap, A.P. and Denton, R.M. (1975) The Specificity and Metabolic Implications of the Inhibition of Pyruvate Transport in Isolated Mitochondria and Intact Tissue Preparations by alpha-Cyano-4-hydroxycinnamate and Related Compounds. Biochemical Journal, 148, 97-106.

[4]   Thomas, A.P. and Halestrap, A.P. (1981) Identification of the Protein Responsible for Pyruvate Transport into Rat Liver and Heart Mitochondria by Specific Labelling with [3H]N-Phenylmaleimide. Biochemical Journal, 196, 471-479.

[5]   Schell, J.C. and Rutter, J. (2013) The Long and Winding Road to the Mitochondrial Pyruvate Carrier. Cancer & Metabolism, 1, 6.

[6]   Gray, L.R., Tompkins, S.C. and Taylor, E.B. (2014) Regulation of Pyruvate Metabolism and Human Disease. Cellular and Molecular Life Sciences, 71, 2577-2604.

[7]   Jeoung, N.H., Harris, C.R. and Harris, R.A. (2014) Regulation of Pyruvate Metabolism in Metabolic-Related Diseases. Reviews in Endocrine & Metabolic Disorders, 15, 99-110.

[8]   Palsson-McDermott, E.M. and O’Neill, L.A.J. (2013) The Warburg Effect Then and Now: From Cancer to Inflammatory Diseases. Bioessays, 35, 965-973.

[9]   Warburg, O., Wind, F. and Negelein, E. (1927) The Metabolism of Tumors in the Body. The Journal of General Physiology, 8, 519-530.

[10]   Iqbal, M.A., Gupta, V., Gopinath, P., Mazurek, S. and Bamezai, R.N.K. (2014) Pyruvate Kinase M2 and Cancer: An Updated Assessment. FEBS Letters, 588, 2685-2692.

[11]   Pande, S.V. and Parvin, R. (1978) Pyruvate and Acetoacetate Transport in Mitochondria. A Reappraisal. Journal of Biological Chemistry, 253, 1565-1573.

[12]   Shearman, M.S. and Halestrap, A.P. (1984) The Concentration of the Mitochondrial Pyruvate Carrier in Rat Liver and Heart Mitochondria Determined with Alpha-Cyano-Beta-(1-phenylindol-3-yl)acrylate. Biochemical Journal, 223, 673- 676.

[13]   Bricker, D.K., Taylor, E.B., Schell, J.C., Orsak, T., Boutron, A., Chen, Y.C., Cox, J.E., Cardon, C.M., Van Vranken, J.G., Dephoure, N., Redin, C., Boudina, S., Gygi, S.P., Brivet, M., Thummel, C.S. and Rutter, J. (2012) A Mitochondrial Pyruvate Carrier Required for Pyruvate Uptake in Yeast, Drosophila, and Humans. Science, 337, 96-100.

[14]   Herzig, S., Raemy, E., Montessuit, S., Veuthey, J.L., Zamboni, N., Westermann, B., Kunji, E.R.S. and Martinou, J.C. (2012) Identification and Functional Expression of the Mitochondrial Pyruvate Carrier. Science, 337, 93-96.

[15]   Brailsford, M.A., Thompson, A.G., Kaderbhai, N. and Beechey, R.B. (1986) The Extraction and Reconstitution of the Alpha-Cyanocinnamate-Sensitive Pyruvate Transporter from Castor Bean Mitochondria. Biochemical and Biophysical Research Communications, 140, 1036-1042.

[16]   Nalecz, M.J., Nalecz, K.A., Broger, C., Bolli, R., Wojtczak, L. and Azzi, A. (1986) Extraction, Partial Purification and Functional Reconstitution of Two Mitochondrial Carriers Transporting Keto Acids: 2-Oxoglutarate and Pyruvate. FEBS Letters, 196, 331-336.

[17]   Capuano, F., Di Paola, M., Azzi, A. and Papa, S. (1990) The Monocarboxylate Carrier from Rat Liver Mitochondria. Purification and Kinetic Characterization in a Reconstituted System. FEBS Letters, 261, 39-42.

[18]   Nalecz, M.J., Nalecz, K.A. and Azzi, A. (1991) Purification and Functional Characterisation of the Pyruvate (Monocarboxylate) Carrier from Baker’s Yeast Mitochondria (Saccharomyces cerevisiae). Biochimica et Biophysica Acta, 1079, 87-95.

[19]   Hildyard, J.C.W. and Halestrap, A.P. (2003) Identification of the Mitochondrial Pyruvate Carrier in Saccharomyces cerevisiae. Biochemical Journal, 374, 607-611.

[20]   Todisco, S., Agrimi, G., Castegna, A. and Palmieri, F. (2006) Identification of the Mitochondrial NAD+ Transporter in Saccharomyces cerevisiae. Journal of Biological Chemistry, 281, 1524-1531.

[21]   Da Cruz, S., Xenarios, I., Langridge, J., Vilbois, F., Parone, P.A. and Martinou, J.C. (2003) Proteomic Analysis of the Mouse Liver Mitochondrial Inner Membrane. Journal of Biological Chemistry, 278, 41566-41571.

[22]   Halestrap, A.P. (2012) The Mitochondrial Pyruvate Carrier: Has It Been Unearthed at Last? Cell Metabolism, 16, 141-143.

[23]   Li, C.L., Wang, M., Ma, X.Y. and Zhang, W. (2014) NRGA1, a Putative Mitochondrial Pyruvate Carrier, Mediates ABA Regulation of Guard Cell Ion Channels and Drought Stress Responses in Arabidopsis. Molecular Plant, 7, 1508-1521.

[24]   Lehmann, J.M., Moore, L.B., Smith-Oliver, T.A., Wilkison, W.O., Willson, T.M. and Kliewer, S.A. (1995) An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-Activated Receptor γ (PPARγ). Journal of Biological Chemistry, 270, 12953-12956.

[25]   Divakaruni, A.S., Wiley, S.E., Rogers, G.W., Andreyev, A.Y., Petrosyan, S., Loviscach, M., Wall, E.A., Yadava, N., Heuck, A.P., Ferrick, D.A., Henry, R.R., McDonald, W.G., Colca, J.R., Simon, M.I., Ciaraldi, T.P. and Murphy, A.N. (2013) Thiazolidinediones Are Acute, Specific Inhibitors of the Mitochondrial Pyruvate Carrier. Proceedings of the National Academy of Sciences of the United States of America, 110, 5422-5427.

[26]   Hardie, D.G. (2014) AMPK: Positive and Negative Regulation, and Its Role in Whole-Body Energy Homeostasis. Current Opinion in Cell Biology, 33C, 1-7.

[27]   Colca, J.R., McDonald, W.G., Cavey, G.S., Cole, S.L., Holewa, D.D., Brightwell-Conrad, A.S., Wolfe, C.L., Wheeler, J.S., Coulter, K.R., Kilkuskie, P.M., Gracheva, E., Korshunova, Y., Trusgnich, M., Karr, R., Wiley, S.E., Divakaruni, A.S., Murphy, A.N., Vigueira, P.A., Finck, B.N. and Kletzien, R.F. (2013) Identification of a Mitochondrial Target of Thiazolidinedione Insulin Sensitizers (mTOT)—Relationship to Newly Identified Mitochondrial Pyruvate Carrier Proteins. PLoS ONE, 8, e61551.

[28]   Vigueira, P.A., McCommis, K.S., Schweitzer, G.G., Remedi, M.S., Chambers, K.T., Fu, X., McDonald, W.G., Cole, S.L., Colca, J.R., Kletzien, R.F., Burgess, S.C. and Finck, B.N. (2014) Mitochondrial Pyruvate Carrier 2 Hypomorphism in Mice Leads to Defects in Glucose-Stimulated Insulin Secretion. Cell Reports, 7, 2042-2053.

[29]   Vacanti, N.M., Divakaruni, A.S., Green, C.R., Parker, S.J., Henry, R.R., Ciaraldi, T.P., Murphy, A.N. and Metallo, C.M. (2014) Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier. Molecular Cell, 56, 425-435.

[30]   Yang, C., Sudderth, J., Dang, T., Bachoo, R.M., Bachoo, R.G., McDonald, J.G. and DeBerardinis, R.J. (2009) Glioblastoma Cells Require Glutamate Dehydrogenase to Survive Impairments of Glucose Metabolism or Akt Signaling. Cancer Research, 69, 7986-7993.

[31]   Yang, C., Ko, B., Hensley, C.T., Jiang, L., Wasti, A.T., Kim, J., Sudderth, J., Calvaruso, M.A., Lumata, L., Mitsche, M., Rutter, J., Merritt, M.E. and DeBerardinis, R.J. (2014) Glutamine Oxidation Maintains the TCA Cycle and Cell Survival during Impaired Mitochondrial Pyruvate Transport. Molecular Cell, 56, 414-424.

[32]   Cairns, R.A., Harris, I.S. and Mak, T.W. (2011) Regulation of Cancer Cell Metabolism. Nature Reviews Cancer, 11, 85-95.

[33]   Schell, J.C., Olson, K.A., Jiang, L., Hawkins, A.J., Van Vranken, J.G., Xie, J., Egnatchik, R.A., Earl, E.G., DeBerardinis, R.J. and Rutter, J. (2014) A Role for the Mitochondrial Pyruvate Carrier as a Repressor of the Warburg Effect and Colon Cancer Cell Growth. Molecular Cell, 56, 400-413.

[34]   Moreb, J.S. (2008) Aldehyde Dehydrogenase as a Marker for Stem Cells. Current Stem Cell Research & Therapy, 3, 237-246.

[35]   Tirino, V., Desiderio, V., Paino, F., De Rosa, A., Papaccio, F., La Noce, M., Laino, L., De Francesco, F. and Papaccio, G. (2013) Cancer Stem Cells in Solid Tumors: An Overview and New Approaches for Their Isolation and Characterization. FASEB Journal, 27, 13-24.

[36]   Leushacke, M. and Barker, N. (2012) Lgr5 and Lgr6 as Markers to Study Adult Stem Cell Roles in Self-Renewal and Cancer. Oncogene, 31, 3009-3022.

[37]   Zhou, J., Ng, S.B. and Chng, W.J. (2013) LIN28/LIN28B: An Emerging Oncogenic Driver in Cancer Stem Cells. International Journal of Biochemistry & Cell Biology, 45, 973-978.

[38]   Iv Santaliz-Ruiz, L.E., Xie, X., Old, M., Teknos, T.N. and Pan, Q. (2014) Emerging Role of Nanog in Tumorigenesis and Cancer Stem Cells. International Journal of Cancer, 135, 2741-2748.